OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 24, 2022
TFF Pharmaceuticals announces findings that inhaled niclosamide significantly inhibits viral replication of the Omicron variant of SARS-CoV-2.
October 15, 2021
Experts share best practices in designing, manufacturing, and scaling up dry powder inhaler and metered dose inhaler drug–device combination products for inhalation drug delivery.
September 16, 2021
Considering interactions and understanding regulatory requirements are crucial when developing a drug or biologic product for use with a medical device.
July 16, 2021
ImmunityBio will proceed with a Phase I/II/III trial in South Africa of their dual-antigen T-cell vaccine as a boost in participants who were previously vaccinated against COVID-19.
May 03, 2021
Aprecia and Glatt investigate manufacturing technologies to widen the formulation design space for oral delivery.
April 21, 2021
The collaboration will evaluate Nanoform’s fast dissolution nanoparticles in Aprecia’s ZipDose 3DP technology platform for buccal and oral drug delivery.
April 03, 2021
Topical drugs are attractive to patients, but these complex products pose challenges for formulators.
March 15, 2021
Smart packaging opens doors to new products for diagnosis and treatment of eye problems.
September 03, 2020
A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing.
June 24, 2020
Inovio received a $71-million contract from the US Department of Defense to scale up manufacture of its Cellectra smart device to deliver its DNA vaccine.